Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

IMM-H007 reduces atherosclerotic plaque in mice and increases circulating HDL levels

April 30, 2014

Novel agent for neuropsychiatric disorders presented by IntraCellular Therapies

April 30, 2014

CCTA-1523 reverses ABCG2-mediated multidrug resistance in cancer cells

April 30, 2014

Jubilant Biosys identifies compounds active against mutant EGFR

April 30, 2014

Chloroquine derivative developed for improving anticancer activity

April 30, 2014

Phase I results of attenuated malaria PfSPZ vaccine presented

April 29, 2014

Control of multiple sclerosis-related central inflammation with ATX-MS-1467

April 29, 2014

F-17727 shows antifibrillatory effects in vivo

April 29, 2014

Preclinical and early clinical data presented for JNJ-42756493

April 29, 2014

OXPHOS inhibitors: a novel class of oncology therapeutics

April 29, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...